InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Brinkley Ruth Williams, 董事. Insider active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 11 filings have been published. History available since 14 September 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Brinkley Ruth Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
86 股Common StockSEC:0001344381-26-000002:0
73 股Common StockSEC:0001344381-26-000001:0
97 股Common StockSEC:0001344381-25-000005:0
112 股Common StockSEC:0001415889-25-020519:0
2,143 股Common StockSEC:0001415889-25-018840:0
6,500 股0Common StockSEC:0001415889-25-013504:0
2,964 股Common StockSEC:0001415889-24-019069:0
6,500 股0Common StockSEC:0001415889-24-012852:0
4,500 股0Common StockSEC:0001209191-23-030963:0
3,000 股0Common StockSEC:0001209191-22-028704:0
5,250 股0Common StockSEC:0001209191-21-056459:0
11 条申报中的 11 条
About Brinkley Ruth Williams
Ruth Williams Brinkley is a Board Member at Travere Therapeutics, Inc. She plays a crucial role in overseeing the company's activities and making strategic decisions. With her experience in the industry, she contributes to implementing effective governance practices and achieving the company's objectives. Her commitment to innovation and corporate social responsibility is a valuable asset to the board.
